Hopital de Pontchaillou; Service de Pneumologie

Rennes 35033

0 studies enrolling now · 4 studies all time

What they study most

Idiopathic Pulmonary Fibrosis, Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer

Studies at this site

• A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131] — Completed
• A Study of Atezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing Therapy — Completed
• A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) — Completed
• Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF) — Completed